These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 4508928

  • 1. Fibrin-stabilizing factor inhibitors.
    Nilsson JL, Stenberg P, Ljunggren C, Hoffman KJ, Lundén R, Eriksson O, Lorand L.
    Ann N Y Acad Sci; 1972 Dec 08; 202():286-96. PubMed ID: 4508928
    [No Abstract] [Full Text] [Related]

  • 2. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma.
    Lorand L.
    Ann N Y Acad Sci; 1972 Dec 08; 202():6-30. PubMed ID: 4565370
    [No Abstract] [Full Text] [Related]

  • 3. Titration of the acceptor cross-linking sites in fibrin.
    Lorand L, Chenoweth D, Gray A.
    Ann N Y Acad Sci; 1972 Dec 08; 202():155-71. PubMed ID: 4508920
    [No Abstract] [Full Text] [Related]

  • 4. Tissue transamidases, fibrin stabilization and clot lysis.
    Tyler HM.
    Ann N Y Acad Sci; 1972 Dec 08; 202():273-85. PubMed ID: 4565369
    [No Abstract] [Full Text] [Related]

  • 5. Cross-linking of fibrin by fibrin=stabilizing factor.
    McKee PA, Schwartz ML, Pizzo SV, Hill RL.
    Ann N Y Acad Sci; 1972 Dec 08; 202():127-48. PubMed ID: 4565368
    [No Abstract] [Full Text] [Related]

  • 6. Fibrin-stabilizing factor inhibitors. II. The inhibitory properties of various aliphatic amines.
    Stenberg P, Nilsson JL, Eriksson O, Lundén R.
    Acta Pharm Suec; 1971 Sep 08; 8(4):415-22. PubMed ID: 5135175
    [No Abstract] [Full Text] [Related]

  • 7. Fibrin-stabilizing factor inhibitors. 11. Monodansylated weak aliphatic diamines.
    Ljunggren C, Hoffmann KJ, Stenberg P, Svensson U, Nilsson JL, Hartkoorn A, Lundén R.
    J Med Chem; 1974 Jun 08; 17(6):649-51. PubMed ID: 4829944
    [No Abstract] [Full Text] [Related]

  • 8. Hereditary aspects of fibrin cross-linking.
    Hampton JW, Garrison D, Morton RO, Bannerjee D.
    Ann N Y Acad Sci; 1972 Dec 08; 202():204-12. PubMed ID: 4629551
    [No Abstract] [Full Text] [Related]

  • 9. Enzymatic coupling of isoniazid to proteins.
    Lorand L, Campbell LK, Robertson BJ.
    Biochemistry; 1972 Feb 01; 11(3):434-8. PubMed ID: 4110351
    [No Abstract] [Full Text] [Related]

  • 10. The influence of fibrin crosslinking on the kinetics of urokinase-induced clot lysis.
    McDonagh RP, McDonagh J, Duckert F.
    Br J Haematol; 1971 Sep 01; 21(3):323-32. PubMed ID: 5569526
    [No Abstract] [Full Text] [Related]

  • 11. Kinetics of transamidating enzymes. Production of thiol in the reactions of thiol esters with fibrinoligase.
    Curtis CG, Stenberg P, Brown KL, Baron A, Chen K, Gray A, Simpson I, Lorand L.
    Biochemistry; 1974 Jul 30; 13(16):3257-62. PubMed ID: 4841063
    [No Abstract] [Full Text] [Related]

  • 12. Fibrin-stabilizing factor inhibitors. I. Amides and esters of trans-4-(aminomethyl)cyclohexane carboxylic acid (tranexamic acid).
    Nilsson JL, Stenberg P, Eriksson O, Lundén R.
    Acta Pharm Suec; 1970 Sep 30; 7(4):441-8. PubMed ID: 5480084
    [No Abstract] [Full Text] [Related]

  • 13. Experimental studies on the production of pulmonary infarction. IV. Effects of UK, heparin, t-AMCHA or ellagic acid.
    Hasegawa H, Watanabe N, Kakizaki H, Murata H.
    Jpn Heart J; 1973 Jul 30; 14(4):335-49. PubMed ID: 4542948
    [No Abstract] [Full Text] [Related]

  • 14. Fibrin-stabilizing factor inhibitors. 12. 5-Dibenzylaminopentylamine and related compounds, a new type of FSF inhibitors.
    Hoffmann KJ, Stenberg P, Ljunggren C, Svensson U, Nilsson JL.
    J Med Chem; 1975 Mar 30; 18(3):278-84. PubMed ID: 1133818
    [Abstract] [Full Text] [Related]

  • 15. Kinetic studies with transglutaminases. The human blood enzymes (activated coagulation factor 13 and the guinea pig hair follicle enzyme.
    Chung SI, Folk JE.
    J Biol Chem; 1972 May 10; 247(9):2798-807. PubMed ID: 4623561
    [No Abstract] [Full Text] [Related]

  • 16. A new assay method for factor XIII using a fluorescence polarization analyzer, based on change in the rotary brownian motion.
    Yamada K, Meguro T.
    Thromb Res; 1977 Nov 10; 11(5):557-66. PubMed ID: 563114
    [No Abstract] [Full Text] [Related]

  • 17. [Modern data on the chemistry and physiology of fibrinogen].
    Andreenko GV.
    Usp Sovrem Biol; 1974 Nov 10; 77(1):51-69. PubMed ID: 4282801
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the fibrin plate method for estimating plasminogen activators.
    Marsh NA, Arocha-Pinango CL.
    Thromb Diath Haemorrh; 1972 Aug 31; 28(1):75-88. PubMed ID: 4672652
    [No Abstract] [Full Text] [Related]

  • 19. The activation of plasma factor XIII with the snake venom enzymes ancrod and batroxobin marajoensis.
    Walter M, Nyman D, Krajnc V, Duckert F.
    Thromb Haemost; 1977 Aug 31; 38(2):438-46. PubMed ID: 579487
    [Abstract] [Full Text] [Related]

  • 20. Our ancient heritage in blood clotting and some of its consequences.
    Laki K.
    Ann N Y Acad Sci; 1972 Dec 08; 202():297-307. PubMed ID: 4508929
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.